{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:29:45Z","timestamp":1791725385024,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cyto.2025.157078","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:53:19Z","timestamp":1764593599000},"page":"157078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["FOXC1 ameliorates the disease progression of psoriasis through transcriptional upregulation of SOCS3"],"prefix":"10.1016","volume":"197","author":[{"given":"Ziyu","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cyto.2025.157078_bb0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.gpb.2015.04.002","article-title":"Biomarkers of an autoimmune skin disease\u2014psoriasis","volume":"13","author":"Jiang","year":"2015","journal-title":"Genom. Proteom. Bioinform."},{"issue":"10281","key":"10.1016\/j.cyto.2025.157078_bb0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"9997","key":"10.1016\/j.cyto.2025.157078_bb0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.cyto.2025.157078_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells12192352","article-title":"The role of sphingolipids and sphingosine-1-phosphate-sphingosine-1-phosphate-receptor signaling in psoriasis","volume":"12","author":"Masuda-Kuroki","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.cyto.2025.157078_bb0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expert Opin. Drug Discovery"},{"issue":"8","key":"10.1016\/j.cyto.2025.157078_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084457","article-title":"Psoriasis and systemic inflammatory disorders","volume":"23","author":"Tashiro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.cyto.2025.157078_bb0035","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"17","key":"10.1016\/j.cyto.2025.157078_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713313","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2025.157078_bb0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1101\/gad.14.2.142","article-title":"Unified nomenclature for the winged helix\/forkhead transcription factors","volume":"14","author":"Kaestner","year":"2000","journal-title":"Genes Dev."},{"issue":"28","key":"10.1016\/j.cyto.2025.157078_bb0055","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/onc.2017.48","article-title":"FOXC1: an emerging marker and therapeutic target for cancer","volume":"36","author":"Han","year":"2017","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cyto.2025.157078_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00018-004-4365-8","article-title":"Forkhead transcription factors in immunology","volume":"62","author":"Jonsson","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.cyto.2025.157078_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020184","article-title":"The diverse consequences of FOXC1 deregulation in cancer","volume":"11","author":"Gilding","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.cyto.2025.157078_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/hmg\/ddm326","article-title":"FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A","volume":"17","author":"Berry","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cyto.2025.157078_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112465","article-title":"Remdesivir ameliorates ulcerative colitis-propelled cell inflammation and pyroptosis in acetic acid rats by restoring SIRT6\/FoxC1 pathway","volume":"137","author":"Oraby","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.cyto.2025.157078_bb0080","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2020.11.002","article-title":"A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2\/FOXC1 axis","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jid.2016.08.012","article-title":"Foxc1 ablated mice are anhidrotic and recapitulate features of human miliaria sweat retention disorder","volume":"137","author":"Cui","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2025.157078_bb0090","article-title":"Interleukin 17 promotes expression of alarmins S100A8 and S100A9 during the inflammatory response of keratinocytes","volume":"11","author":"Christmann","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2025.157078_bb0095","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.jid.2023.02.026","article-title":"S100A9 drives the chronification of psoriasiform inflammation by inducing IL-23\/type 3 immunity","volume":"143","author":"Silva de Melo","year":"2023","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.cyto.2025.157078_bb0100","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/annrheumdis-2022-222229","article-title":"Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease","volume":"81","author":"Mellor","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2025.157078_bb0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2012.05.162","article-title":"S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin","volume":"423","author":"Lee","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.cyto.2025.157078_bb0110","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/jid.2013.199","article-title":"Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model","volume":"133","author":"Nakajima","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.cyto.2025.157078_bb0115","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","article-title":"S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3","volume":"39","author":"Schonthaler","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.cyto.2025.157078_bb0125","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2025.157078_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jdv.12106","article-title":"Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies","volume":"28","author":"Mattei","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.cyto.2025.157078_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/cpr.12168","article-title":"IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes","volume":"48","author":"Hsieh","year":"2015","journal-title":"Cell Prolif."},{"issue":"10","key":"10.1016\/j.cyto.2025.157078_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102636","article-title":"PI3K\u03b4 sustains keratinocyte hyperproliferation and epithelial inflammation: implications for a topically druggable target in psoriasis","volume":"10","author":"Mercurio","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2025.157078_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109615","article-title":"Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models","volume":"121","author":"Jiang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.cyto.2025.157078_bb0150","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41419-023-06234-9","article-title":"Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 pathway activation and attenuating inflammatory signaling","volume":"14","author":"Ma","year":"2023","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cyto.2025.157078_bb0155","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.7150\/thno.89180","article-title":"Keratinocyte-to-macrophage communication exacerbate psoriasiform dermatitis via LRG1-enriched extracellular vesicles","volume":"14","author":"Jiang","year":"2024","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.cyto.2025.157078_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041412","article-title":"Coptisine alleviates imiquimod-induced psoriasis-like skin lesions and anxiety-like behavior in mice","volume":"27","author":"Nguyen","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.cyto.2025.157078_bb0165","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200471","article-title":"Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-\u03baB\/MAPK pathway","volume":"40","author":"Liu","year":"2020","journal-title":"Biosci. Rep."},{"issue":"17","key":"10.1016\/j.cyto.2025.157078_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176206","article-title":"Oxidative stress as an important contributor to the pathogenesis of psoriasis","volume":"21","author":"Ple\u0144kowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cyto.2025.157078_bb0175","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.freeradbiomed.2009.06.033","article-title":"Oxidative stress in the pathogenesis of psoriasis","volume":"47","author":"Zhou","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamadermatol.2024.4433","article-title":"Skin inflammation, systemic inflammation, and cardiovascular disease in psoriasis","volume":"161","author":"Svedbom","year":"2025","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0185","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1038\/s41467-024-50993-8","article-title":"Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment","volume":"15","author":"Abboud","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2025.157078_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111679","article-title":"Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway","volume":"130","author":"Bharatha","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42019-y","article-title":"Regulation of psoriasis, colitis, and the intestinal microbiota by clusterin","volume":"13","author":"Jun","year":"2023","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.cyto.2025.157078_bb0200","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/jid.2014.194","article-title":"Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization","volume":"134","author":"Aspord","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.cyto.2025.157078_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062979","article-title":"Psoriasis: pathogenesis, comorbidities, and therapy updated","volume":"22","author":"Kanda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cyto.2025.157078_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1032","article-title":"Emerging role of I\u03baB\u03b6 in inflammation: emphasis on psoriasis","volume":"12","author":"Gautam","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cyto.2025.157078_bb0215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fimmu.2019.00182","article-title":"Alarmins of the S100-family in juvenile autoimmune and auto-inflammatory diseases","volume":"10","author":"Holzinger","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2025.157078_bb0220","article-title":"The involvement of oxidative stress in psoriasis: a systematic review","volume":"11","author":"Dobric\u0103","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.cyto.2025.157078_bb0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.31083\/j.fbl2806118","article-title":"The role of oxidative stress in the induction and development of psoriasis","volume":"28","author":"Blagov","year":"2023","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s10020-021-00271-w","article-title":"ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia\/reperfusion injury by regulating autophagy","volume":"27","author":"Chen","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.cyto.2025.157078_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1393799","article-title":"SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation","volume":"15","author":"Morelli","year":"2024","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.cyto.2025.157078_bb0240","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1007\/s00018-014-1619-y","article-title":"SOCS proteins in regulation of receptor tyrosine kinase signaling","volume":"71","author":"Kazi","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.cyto.2025.157078_bb0245","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10787-019-00605-5","article-title":"Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis","volume":"27","author":"Lee","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.cyto.2025.157078_bb0250","article-title":"Socs3 expression in myeloid cells modulates the pathogenesis of dextran sulfate sodium (DSS)-induced colitis","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0255","doi-asserted-by":"crossref","first-page":"15830","DOI":"10.1038\/s41598-017-16155-1","article-title":"Insights into gene expression profiles induced by Socs3 depletion in keratinocytes","volume":"7","author":"Bajpai","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cyto.2025.157078_bb0260","article-title":"In vitro significance of SOCS-3 and SOCS-4 and potential mechanistic links to wound healing","volume":"7","author":"Feng","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662500225X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662500225X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:37:34Z","timestamp":1766144254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662500225X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":52,"alternative-id":["S104346662500225X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157078","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXC1 ameliorates the disease progression of psoriasis through transcriptional upregulation of SOCS3","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157078"}}